Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RBM25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF2S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB3IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL2BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00507 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC00844 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACVR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507507 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TM4SF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NACA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC1A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on